Abstract
HIV-associated neurocognitive disorders (HAND) are a common neurological manifestation of HIV infection. A previous study suggested that HIV dementia may be more common among patients with subtype D virus than among those with subtype A virus among HIV+ individuals with advanced immunosuppression. We conducted a study to evaluate the frequency of HIV dementia, and the association of HIV dementia with HIV subtype and compartmentalization among HIV+ individuals with moderate and advanced immunosuppression (CD4 lymphocyte count >150 cells/μL and <250 cells/μL). The study enrolled 117 antiretroviral naïve HIV+ individuals in Kampala, Uganda. HIV+ individuals received neurological, neuropsychological testing, and functional assessments, and gag and gp41 regions were subtyped. Subjects were considered infected with a specific subtype if both regions analyzed were from the same subtype. 41 % of the HIV+ individuals had HIV dementia (mean CD4 lymphocyte count = 233 cells/μL). 67 individuals had subtype A, 25 individuals had subtype D, 24 individuals were classified as A/D recombinants, and one individual had subtype C. There was no difference in the frequency of HIV dementia when stratified by HIV subtype A and D and no association with compartmentalization between the cerebrospinal fluid and peripheral blood. These results suggest that HIV dementia is common in HIV+ individuals in Uganda. There was no association between HIV subtype and dementia among HIV+ individuals with moderate and advanced immunosuppression. Future studies should be performed to confirm these results.
Similar content being viewed by others
Abbreviations
- HIV:
-
Human immunodeficiency virus
- HAND:
-
HIV-associated neurocognitive disorders
- CSF:
-
Cerebrospinal fluid
- AIDS:
-
Acquired immunodeficiency syndrome
- CNS:
-
Central nervous system
- env:
-
Envelope
- ART:
-
Antiretroviral therapy
- ELISA:
-
Enzyme-linked immunosorbent assay
- RNA:
-
Ribonucleic acid
- ANI:
-
Asymptomatic neurocognitive impairment
- MND:
-
Mild neurocognitive disorder
- SD:
-
Standard deviation
- nt:
-
Nucleotide
- CLUSTALW:
-
Cluster analysis program-W
- BIO edit:
-
Biological sequence alignment editor
- PHYLIP:
-
Phylogeny inference package
- GenBank-NIH:
-
Genetic sequence database bank
- gag:
-
Group specific antigen
- gp41:
-
Glycoprotein 41
- NGS:
-
Next generation sequencing
- emPCR:
-
Emulsion based polymerase chain reaction
- DNA:
-
Deoxyribonucleic acid
- ANOVA:
-
Analysis of variance
- μL:
-
Microliter
- CCR-5:
-
cc-chemokine receptor type 5
- CXCR4- C-X-C:
-
Chemokine receptor type 4
References
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd D et al (2007) Updated research nosology for HIV-associated neurocognitive disorders (HAND). Neurology 69(18):1789–1799
Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS et al (2007) HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 195(8):1177–1180
Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H et al (2010) HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS 24(8):1163–1170
Carr JK, Salminen MO, Koch C, Gotte D, Artenstein AW et al (1996) Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 70(9):5935–5943
Conroy SA, Laeyendecker O, Redd AD, Collinson-Streng A, Kong X et al (2010) Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. AIDS Res Hum Retrovir 26(10):1087–1091
Felsentein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791
Gabuzda D, Wang J (2000) Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol 6(Suppl 1):S24–S32
Hall TA (1999) BioEdit: a user-friendly biological sequencealignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:95–98
Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K et al (2009) Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS 23(8):907–915
Kaleebu P, French N, Mahe C, Yirrell D, Watera C et al (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185(9):1244–1250
Kaleebu P, Nankya IL, Yirrell DL, Shafer LA, Kyosiimire-Lugemwa J et al (2007) Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr 45(1):28–33
Karnofsky DA, Abelman WH, Craver LF, Burchenal J (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656
Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M et al (2008) Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 197(5):707–713
Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS et al (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73(1):152–160
Maj M, Satz P, Janssen R, Zaudig M, Starace F et al (1994) WHO Neuropsychiatric AIDS Study. Cross-sectional Phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry 51:51–61
Redd AD, Collinson-Streng A, Martens C, Ricklefs S, Mullis CE et al (2011) Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J Clin Microbiol 49(8):2859–2867
Redd AD, Mullis CE, Serwadda D, Kong X, Martens C et al (2012) The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J Infect Dis 206(2):267–274
Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E et al (2007) Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol 7:8
Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA et al (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19(13):1367–1374
Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M et al (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67(2):311–314
Sacktor N, Nakasujja N, Skolasky R, Liner J, Robertson K et al (2007) Neurocognitive improvement with antiretroviral therapy among HIV+ individuals in Sub-Saharan Africa. Neurology A:139–40 (Abstr.)
Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K et al (2009) HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49(5):780–786
Sacktor N, Nakasujja N, Okonkwo O, Skolasky RL, Robertson K et al (2013) Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda. J Neurovirol 19(1):48–56
Smith A (1982) Symbol digit modalities test. Western psychological service
Vallat AV, DeGirolami U, He JL, Mhashilkar A, Marasco W et al (1998) Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152:167–178
Wambui V, Kiptoo M, Kinyua J, Odera I, Muge E et al (2012) Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic. AIDS Res Ther 9(1):22
Wong M, Robertson K, Nakasujja N, Skolasky R, Musisi S et al (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68:350–355
Yang C, Dash BC, Simon F, van der GG, Pieniazek D et al (2000) Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis 181(5):1791–1795
Yang C, Dash B, Hanna SL, Frances HS, Nzilambi N et al (2001) Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa. Democratic Republic of Congo. AIDS Res Hum Retrovir 17(4):361–365
Funding
This work was supported by the National Institute of Mental Health at the National Institutes of Health (Grant number MH083465). Funding also was provided in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Conflict of interest
The authors have no conflicts of interest to report with the following exception: Dr. Robertson has performed consulting work with ViiV and Abbott.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sacktor, N., Nakasujja, N., Redd, A.D. et al. HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda. Metab Brain Dis 29, 261–268 (2014). https://doi.org/10.1007/s11011-014-9498-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9498-3